Professor of Medicine, UCLA-David Geffen School of Medicine
Infectious Disease
Dr. Judith S. Currier, MD
|
|
Give Review
Judith S. Currier practices Infectious Disease. She researched medicine at Geisel School of Medicine at Dartmouth. Geisel School of Medicine at Dartmouth is ranked 37/29 in Research/PrimaryCare. She received 3 awards: "Top Doctors:LA Area", "Top Doctors:Southern California" and "Super Doctor". Judith S. Currier has written publications. She has 65 publications published with PubMed. The lastest paper is: 'Vitamin D Levels and Markers of Inflammation and Metabolism in HIV-Infected Individuals on Suppressive Antiretroviral Therapy.' Judith S. Currier, MD accepts Medicare.
Publications
- Vitamin D Levels and Markers of Inflammation and Metabolism in HIV-Infected Individuals on Suppressive Antiretroviral Therapy.
- Benefits of PrEP as an Adjunctive Method of HIV Prevention During Attempted Conception Between HIV-uninfected Women and HIV-infected Male Partners.
- Comparison of the Metabolic Effects of Ritonavir boosted Darunavir or Atazanavir versus Raltegravir, and the Impact of Ritonavir Plasma Exposure: ACTG 5257.
- Stimulating High Impact HIV-Related Cardiovascular Research: Recommendations From a Multidisciplinary NHLBI Working Group on HIV-Related Heart, Lung, and Blood Disease.
- The effect of hepatitis C virologic clearance on cardiovascular disease biomarkers in human immunodeficiency virus/hepatitis C virus coinfection.
- Dyslipidemia and Cardiovascular Risk in Human Immunodeficiency Virus Infection.
- Antiretroviral Therapy and Efficacy after Virologic Failure on First-line Boosted Protease Inhibitor Regimens.
- Arterial Disease in Patients With Human Immunodeficiency Virus Infection: What Has Imaging Taught Us?
- CROI 2014: viral hepatitis and complications of HIV disease and antiretroviral therapy.
- Cardiovascular Disease Risk Factors in HIV-Infected Women Following Initiation of Lopinavir/ritonavir- and Nevirapine-based Antiretroviral Therapy in Sub-Saharan Afric...
- HDL redox activity is increased in HIV-infected men in association with macrophage activation and noncalcified coronary atherosclerotic plaque.
- Renal events among women treated with tenofovir/emtricitabine in combination with either lopinavir/ritonavir or nevirapine: analysis from the AIDS Clinical Trial Group...
- Metabolic disease in HIV infection.
- Insights on GRACE (Gender, Race, And Clinical Experience) from the Patient's Perspective: GRACE Participant Survey.
- Biomarkers from Late Pregnancy to Six Weeks Postpartum in HIV-infected Women who Continue versus Discontinue Antiretroviral Therapy after Delivery.
- Body Composition, Soluble Markers of Inflammation, and Bone Mineral Density in Antiretroviral Therapy-Naïve HIV-1 Infected Individuals.
- A Pilot Study of Telmisartan for Visceral Adiposity in HIV Infection: The Metabolic Abnormalities, Telmisartan, and HIV Infection (MATH) Trial.
- Characterization of HIV-HBV co-infection in a multi-national HIV-infected cohort.
- Perturbations of circulating levels of RANKL-Osteoprotegerin Axis in Relation to Lipids and Progression of Atherosclerosis in HIV-Infected and -Uninfected Adults: ACTG...
- Ultrasonographic measures of cardiovascular disease risk in antiretroviral treatment-naive individuals with HIV infection.
- Biomarkers of microbial translocation and macrophage activation: association with progression of subclinical atherosclerosis in HIV-1 infection.
- A Randomized Trial of Raltegravir Replacement for Protease Inhibitor or Non-Nucleoside Reverse Transcriptase Inhibitor in HIV-Infected Women with Lipohypertrophy.
- Complications of HIV disease and antiretroviral therapy.
- Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in Los Angeles County.
- Nevirapine pharmacokinetics and risk of rash and hepatitis among HIV-infected sub-Saharan African women.
- HIV-1 Protease Inhibitors and Clinical Malaria: a Secondary Analysis of the AIDS Clinical Trials Group A5208 Study.
- A Biochemical Fluorometric Method for Assessing the Oxidative Properties of HDL.
- Effects of darunavir/ritonavir-based therapy on metabolic and anthropometric parameters in women and men over 48 weeks.
- Role of low-frequency HIV-1 variants in failure of nevirapine-containing antiviral therapy in women previously exposed to single-dose nevirapine.
- Sex differences in lopinavir and ritonavir pharmacokinetics among HIV-infected women and men.
- Switching antiretroviral therapy to minimize metabolic complications.
- Complications of HIV disease and antiretroviral treatment.
- Clinical practice. Postexposure prophylaxis for HIV infection.
- Update on cardiovascular complications in HIV infection.
- Availability of HIV postexposure prophylaxis services in Los Angeles County.
- Determinants of participation in HIV clinical trials: the importance of patients' trust in their provider.
- Lymphoma diagnosis and plasma Epstein-Barr virus load during vicriviroc therapy: results of the AIDS Clinical Trials Group A5211.
- Coronary atherosclerotic lesions in human immunodeficiency virus-infected patients: a histopathologic study.
- Safety and efficacy of initiating highly active antiretroviral therapy in an integrated antenatal and HIV clinic in Johannesburg, South Africa.
- Calcification of the internal elastic lamina of coronary arteries.
- State of the science conference: Initiative to decrease cardiovascular risk and increase quality of care for patients living with HIV/AIDS: executive summary.
- Guidelines for managing cardiovascular risk: an evolving area.
- Highlights of the 15th Conference on Retroviruses and Opportunistic Infections. Complications of HIV disease and therapy.
- Atherosclerotic oxalosis in coronary arteries.
- Primary human immunodeficiency virus type 1 (HIV-1) infection during HIV-1 Gag vaccination.
- Mönckeberg sclerosis revisited: a clarification of the histologic definition of Mönckeberg sclerosis.
- Evaluation of sex differences of fosamprenavir (with and without ritonavir) in HIV-infected men and women.
- Sex differences in antiretroviral therapy toxicity: lactic acidosis, stavudine, and women.
- Complications of HIV disease and therapy.
- Management of antiretroviral treatment-related complications.
- Getting smarter--the toxicity of undertreated HIV infection.
- Lipids, metabolic syndrome, and risk factors for future cardiovascular disease among HIV-infected patients.
- Sex Differences in HIV: Natural History, Pharmacokinetics, and Drug Toxicity.
- Complications of HIV disease and antiretroviral therapy. Highlights of the 11th Conference on Retroviruses and Opportunistic Infections, February 8-11, 2004, San Franc...
- Coronary heart disease in HIV-infected individuals.
- Complications of HIV infection and antiretroviral therapy.
- HIV Infection in Women: Selected Issues in Pregnancy.
- Cardiovascular risk associated with HIV therapy.
- Localized osteomyelitis due to Mycobacterium avium complex in patients with Human Immunodeficiency Virus receiving highly active antiretroviral therapy.
- Association of adherence to Mycobacterium avium complex prophylaxis and antiretroviral therapy with clinical outcomes in Acquired Immunodeficiency Syndrome.
- A High Throughput Biochemical Fluorometric Method for Measuring Lipid Peroxidation in HDL.
- CROI 2013: complications of HIV disease, viral hepatitis, and antiretroviral therapy.
- Immune activation markers in peripartum women in botswana: association with feeding strategy and maternal morbidity.
- Urinary Eicosanoid Metabolites in HIV-Infected Women with Central Obesity Switching to Raltegravir: An Analysis from the Women, Integrase, and Fat Accumulation Trial.
Schools
Dartmouth College
Beth Israel Hospital
Brigham WomensBeth Israel
Doctors Specialties
- Infectious Disease Medicine
- Infectious Disease
Accepted Insurances
Awards
- Top Doctors:LA Area
- Top Doctors:Southern California
- Super Doctor
Education
-
Beth Israel Deaconess Medical Center -
Geisel School of Medicine at Dartmouth
Hospital
-
Ronald Reagan UCLA Medical Center -
Santa Monica-UCLA Medical Center and Orthopaedic Hospital
Drug Facts
| NPI NUMBER | 1508882614 | |
| NPPES Provider LastName | CURRIER | |
| NPPES Provider FirstName | JUDITH | |
| NPPES Provider ZIPCode | 900953075 | |
| NPPES Provider State | CA | |
| Specialty Description | Infectious Disease | |
| Total Claim Count | 349.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1508882614 |
| Last Name Of The Provider | CURRIER |
| First Name Of The Provider | JUDITH |
| View All |
Similar Doctors
|
|
Dr. Randy B. Feldman, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Robert A. Larsen, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Joseph J. Cadden, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Suman Radhakrishna, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Joanna M. Schaenman, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Christine Y. Balekian, MD |
|
|
Dr. Peter Katona, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Matthew B. Goetz, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jocelyn T. Kim, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Quen J. Cheng, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Rachel H. Civen, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Michael A. Lovett, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Daniel P. Chelliah, MD
This Doctor is OpenDoctor Recommended.
|